nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
|
Lundgren, Christine |
|
2019 |
178 |
2 |
p. 459-467 |
artikel |
2 |
Allelic modification of breast cancer risk in women with an NBN mutation
|
Rusak, Bogna |
|
2019 |
178 |
2 |
p. 427-431 |
artikel |
3 |
A multicentre, randomized pilot trial comparing vascular access strategies for early stage breast cancer patients receiving non-trastuzumab containing chemotherapy
|
Robinson, Andrew |
|
2019 |
178 |
2 |
p. 337-345 |
artikel |
4 |
A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients
|
Arnaout, Angel |
|
2019 |
178 |
2 |
p. 327-335 |
artikel |
5 |
Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases
|
Liu, Zhe-Bin |
|
2019 |
178 |
2 |
p. 251-261 |
artikel |
6 |
Differences in breast cancer outcomes amongst Black US-born and Caribbean-born immigrants
|
Barreto-Coelho, Priscila |
|
2019 |
178 |
2 |
p. 433-440 |
artikel |
7 |
Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer
|
Hida, Akira I. |
|
2019 |
178 |
2 |
p. 283-294 |
artikel |
8 |
Effect of early adverse events resulting in ado-trastuzumab emtansine dose adjustments on survival outcomes of HER2+ advanced breast cancer patients
|
Tang, Ethan |
|
2019 |
178 |
2 |
p. 473-477 |
artikel |
9 |
Evaluation of phospho-histone H3 in Asian triple-negative breast cancer using multiplex immunofluorescence
|
Lai, Chi Peng Timothy |
|
2019 |
178 |
2 |
p. 295-305 |
artikel |
10 |
Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11)
|
Kim, Ji-Yeon |
|
2019 |
178 |
2 |
p. 367-377 |
artikel |
11 |
Gene expression analysis to detect disseminated tumor cells in the bone marrow of triple-negative breast cancer patients predicts metastatic relapse
|
Siddappa, Chidananda M. |
|
2019 |
178 |
2 |
p. 317-325 |
artikel |
12 |
Genomic landscape of ductal carcinoma in situ and association with progression
|
Lin, Chieh-Yu |
|
2019 |
178 |
2 |
p. 307-316 |
artikel |
13 |
HER2 double-equivocal breast cancer in Chinese patients: a high concordance of HER2 status between different blocks from the same tumor
|
Liu, Yuanyuan |
|
2019 |
178 |
2 |
p. 275-281 |
artikel |
14 |
Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes
|
Viale, Giuseppe |
|
2019 |
178 |
2 |
p. 451-458 |
artikel |
15 |
Letter regarding Sopik V et al. entitled “Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ”
|
Wang, Xiangyu |
|
2019 |
178 |
2 |
p. 481-482 |
artikel |
16 |
Long-term outcome with targeted therapy in advanced/metastatic HER2-positive breast cancer: The Royal Marsden experience
|
Battisti, Nicolò Matteo Luca |
|
2019 |
178 |
2 |
p. 401-408 |
artikel |
17 |
Marital status is an independent prognostic factor in inflammatory breast cancer patients: an analysis of the surveillance, epidemiology, and end results database
|
Liu, Yan-ling |
|
2019 |
178 |
2 |
p. 379-388 |
artikel |
18 |
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
|
He, Jichao |
|
2019 |
178 |
2 |
p. 263-274 |
artikel |
19 |
Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination
|
Swain, Sandra M. |
|
2019 |
178 |
2 |
p. 389-399 |
artikel |
20 |
Phase II randomized controlled trial of hypnosis versus progressive muscle relaxation for body image after breast or gynecologic cancer
|
Barton, Debra L. |
|
2019 |
178 |
2 |
p. 357-365 |
artikel |
21 |
Precision medicine: PI3K targeting in advanced breast cancer
|
Rocca, Andrea |
|
2019 |
178 |
2 |
p. 479 |
artikel |
22 |
Randomized window of opportunity trial evaluating high-dose vitamin D in breast cancer patients
|
Arnaout, Angel |
|
2019 |
178 |
2 |
p. 347-356 |
artikel |
23 |
Rationale for evaluating breast cancers of Lynch syndrome patients for mismatch repair gene expression
|
Sorscher, Steven |
|
2019 |
178 |
2 |
p. 469-471 |
artikel |
24 |
Reliability of preoperative breast biopsies showing ductal carcinoma in situ and implications for non-operative treatment: a cohort study
|
Mannu, Gurdeep S. |
|
2019 |
178 |
2 |
p. 409-418 |
artikel |
25 |
Time-to-surgery and overall survival after breast cancer diagnosis in a universal health system
|
Eaglehouse, Yvonne L. |
|
2019 |
178 |
2 |
p. 441-450 |
artikel |
26 |
Utilization, duration, and outcomes of neoadjuvant endocrine therapy in the United States
|
Pariser, Ashley C. |
|
2019 |
178 |
2 |
p. 419-426 |
artikel |